$8.43
-$0.78
(-8.42%)
Quote as of 11:26 AM EST on 02/10/12
Gentium S.p.A. (ADR)
NASDAQ:GENT
Related Resources
GENT
vs. S&P 500
|
$8.43
-$0.78
(-8.42%)
|
|
| Today's Open | $9.04 |
|---|---|
| Previous Close | $9.20 |
| Daily Range | $8.43 - $9.04 |
| 52-Week Range | $5.31 - $13.69 |
| Market Cap | $126.12M |
| P/E Ratio | 24.21 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 8,050 |
| Average Daily Volume | 53,956 |
| Current FY EPS | $0.26 |
GENT Information
| Description |
|---|
| A biopharmaceutical company engaged in the research, development and manufacture of drugs to treat and prevent a variety of vascular diseases and conditions related to cancer and cancer treatments. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Italian Mess: Does Berlusconi Really Matter?
11/15/2011 by Nasdaq
Market Risks: Now, Everyone Start Freaking Out About Italian Debt
11/3/2011 by Nasdaq
8/12/2011 by DailyFinance
Mama Mia! Keep an Eye on These Italian Stocks
8/11/2011 by Nasdaq
19 Undervalued Micro Caps With EPS Growth of Over 50% for 2011-12
4/6/2011 by Seeking Alpha
19 Undervalued Microcaps With EPS Growth of Over 50% for 2011-12
4/6/2011 by Seeking Alpha
Gentium Swings to Q3 Profit as Drug Sales Jump 97%
11/9/2010 by Seeking Alpha
